January 7, 2011 7:21 AM | 1 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Biomet's results raise two concerns for Deutsche Bank: incremental US pricing and mix pressure; results suggest the US end of year pick-up may not have been thatnotable. However, it notes Biomet has proven it is not always a good proxy forwhat to expect from others. Biomet did acknowledge the possibility it may have lost share. Deutsche Bank thinks the market was indeed soft and pricing/mix pressures are likely to be echoed by others. It continues to rate both Stryker (NYSE: SYK) and Zimmer Holdings (NYSE: ZMH) Hold.Yesterday Biomet reported F2Q11 results. On a worldwide constant currency basis, total sales were up 2%. Recon sales were up just 3%, a deceleration from F1Q11's up 4% andFY2010's up 8% rate. Hip sales were flat while knees were up 3%. Management attributed the softer results to continued deceleration in procedures as well as incremental pricing and mix pressure, needless to say a concerning trend if it proves to be reflective of the overall market trends.The economy continues to weigh on procedure rates. In the U.S. Biomet did notsee any notable change on procedures volumes on a month to month basis, thusthere was no deductible-fueled pick-up as some expected.SYK closed Thursday at $54.64ZMH closed Thursday at $52.60
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.